🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06720948
Enrolling by invitation Observational

The ION Facet Screw System Ambispective Evaluation

NCT06720948 · tracked via the Priya Life Science USA tracker
Sponsor
SurGenTec LLC
Phase
Observational
Started
2025-01-01
Last updated
2026-08-24

Condition(s) studied

Intra-facet ION 3D Facet Screw System

Investigational drug(s) / intervention(s)

ION 3D Facet Screw System

ION 3D Facet Screw System: Observational study of subjects previously implanted with ION 3D Facet Screw System.

Study summary

The purpose of this observational, multi-center, ambispective, serial case study is to collect real-world patient outcomes that characterize the long-term safety and effectiveness of the SurGenTec ION 3D® Facet Screw System in a cervical spine and a lumbar spine application.

Eligibility

Sex
ALL
Min age
21 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Previously implanted intra-facet with one ION® Facet Screw placed per joint bilaterally at one or more contiguous levels of the cervical spine (C3-C7), or one or more contiguous levels of the lumbar spine (L3-S1), * Must have supplemental fixation at the target level(s), * Skeletally mature (minimum age of 21 years but not greater than 80 years), * Be willing and able to comply with the study protocol requirements, and * Be willing to sign the study-specific Informed Consent Document. Exclusion Criteria: * Implanted with the ION Facet Screw System at a spinal level that includes the thoracic spine (T1-T12), * Unilateral fixation with the ION Fact Screw System, * Current active or suspected malignancy, or a cancer diagnosis that was ongoing during the patient's treatment and healing period, * Significant metabolic bone disease (diagnosis of osteoporosis or osteomalacia), * Currently taking medications that are known to potentially interfere with bone healing (e.g. chronic oral/systemic steroids), * Pregnant or nursing female, or * Incarcerated at the time of the required 12-month evaluation.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Orthopaedics Northeast Fort Wayne Indiana
Neuroscience Specialists Oklahoma City Oklahoma
Shannon Clinic San Angelo Texas

More SurGenTec LLC trials in the USA

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06720948 on ClinicalTrials.gov ↗ ← All trials in the USA